| Kevin K Vakili, MD | |
|
269 S Candy Ln, Cottonwood, AZ 86326-4158 | |
| (928) 639-6150 | |
| (928) 639-6561 |
| Full Name | Kevin K Vakili |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 21 Years |
| Location | 269 S Candy Ln, Cottonwood, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497899074 | NPI | - | NPPES |
| 213536 | Medicaid | AZ | |
| P00447273 | Other | AZ | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 36233 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yavapai Regional Medical Center | Prescott, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prescott Anesthesia Pllc | 4385536929 | 13 |
News Archive
Researchers examined the dissemination and evolution of four SARS-CoV-2 lineages as well as the potential that one or more recombination events played a role in their evolution.
Restrictive eating and current or past eating disorders are associated with increased risk of injuries, reveals a study conducted at the Faculty of Sport and Health Sciences at the University of Jyväskylä. The findings also showed that menstrual dysfunction was associated with more missed training/competition days.
Many patients prescribed a medicine for a long term condition, such as asthma or heart disease, rapidly stop taking their medicines as prescribed, reveals research in Quality and Safety in Health Care.
Misunderstandings about proper use of antibiotics have the potential to spread widely through social networks such as Twitter, according to a report in the April issue of AJIC: American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology, Inc. (APIC).
Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.
› Verified 4 days ago
| Entity Name | Prescott Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962409185 PECOS PAC ID: 4385536929 Enrollment ID: O20040327000221 |
News Archive
Researchers examined the dissemination and evolution of four SARS-CoV-2 lineages as well as the potential that one or more recombination events played a role in their evolution.
Restrictive eating and current or past eating disorders are associated with increased risk of injuries, reveals a study conducted at the Faculty of Sport and Health Sciences at the University of Jyväskylä. The findings also showed that menstrual dysfunction was associated with more missed training/competition days.
Many patients prescribed a medicine for a long term condition, such as asthma or heart disease, rapidly stop taking their medicines as prescribed, reveals research in Quality and Safety in Health Care.
Misunderstandings about proper use of antibiotics have the potential to spread widely through social networks such as Twitter, according to a report in the April issue of AJIC: American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology, Inc. (APIC).
Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kevin K Vakili, MD 1200 N Beaver St, Payer Credentialing, Flagstaff, AZ 86001-3118 Ph: (928) 773-2559 | Kevin K Vakili, MD 269 S Candy Ln, Cottonwood, AZ 86326-4158 Ph: (928) 639-6150 |
News Archive
Researchers examined the dissemination and evolution of four SARS-CoV-2 lineages as well as the potential that one or more recombination events played a role in their evolution.
Restrictive eating and current or past eating disorders are associated with increased risk of injuries, reveals a study conducted at the Faculty of Sport and Health Sciences at the University of Jyväskylä. The findings also showed that menstrual dysfunction was associated with more missed training/competition days.
Many patients prescribed a medicine for a long term condition, such as asthma or heart disease, rapidly stop taking their medicines as prescribed, reveals research in Quality and Safety in Health Care.
Misunderstandings about proper use of antibiotics have the potential to spread widely through social networks such as Twitter, according to a report in the April issue of AJIC: American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology, Inc. (APIC).
Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.
› Verified 4 days ago
Dr. Charles A Cluff, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 269 S Candy Ln, Cottonwood, AZ 86326 Phone: 928-639-6150 Fax: 928-639-6561 | |
Preston Clark Roby, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3655 E Penny Ln, Cottonwood, AZ 86326 Phone: 928-634-3902 | |
Dr. Gary Douglas Gridley, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 269 S Candy Ln, Cottonwood, AZ 86326 Phone: 928-639-6150 Fax: 928-639-6561 | |
Ann Carlson, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 269 S Candy Ln, Cottonwood, AZ 86326 Phone: 928-639-6150 Fax: 928-639-6561 | |
Dr. Amy L Gottschalk, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 269 S Candy Ln, Cottonwood, AZ 86326 Phone: 928-639-6150 Fax: 928-639-6561 | |
David Crowell, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 300 W Highway 89a, Cottonwood, AZ 86326 Phone: 602-273-6770 Fax: 602-889-0489 | |
William A. Levinger, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 269 S Candy Ln, Cottonwood, AZ 86326 Phone: 928-639-6150 |